Impact of Silymarin Supplementation on Liver Function and Enzyme Profiles in Diverse Chronic Liver Disease Etiologies
This study demonstrates that silymarin effectively reduces ALT and AST levels and achieves higher ALT normalization compared to standard treatment in CLD patients. While improvements in hepatic encephalopathy, ascites, and CTP class were comparable between groups, silymarin showed greater efficacy in metabolic conditions like NAFLD.
Authors
- Arslan Shamim
- Hafiz Muhammad Zeeshan (ORCID: https://orcid.org/0000-0002-3187-4494)
- Muhammad Umair Hassan (ORCID: https://orcid.org/0000-0001-7607-5154)
- Mahnoor Rehman
- Muhammad Irfan Jamil
- Muhammad Amjad
- Adeel Ahmed
- Zohaib Iftikhar
Institutions
- Nishtar Medical College and Hospital (PK)
- Punjab Medical College (PK)
- Lahore General Hospital (PK)
- Royal Berkshire Hospital (GB)
Publication Details
- Journal
- Cureus
- Published
- 2024-12-24
- DOI
- https://doi.org/10.7759/cureus.76313
- Citations
- 3
- Primary Topic
- Silymarin and Mushroom Poisoning
- Type
- article
- Field-Weighted Citation Impact
- 1.26